(Press-News.org) Patients with a diagnosis of dementia have approximately three times the rate of diagnosis of urinary incontinence, and more than four times the rate of fecal incontinence, compared with those without a diagnosis of dementia, according to a study in this week's issue of PLOS Medicine by Robert Grant (Kingston University and St. George's, University of London) and colleagues. Furthermore, patients with dementia and incontinence were more likely to receive incontinence medications and indwelling catheters than those with incontinence but without dementia, the authors state.
The authors analyzed records of patients in The Health Improvement Network (THIN) database, a database of nearly 500 UK primary care practices. They extracted data on 54,816 people aged 60 years with a diagnosis of dementia and an age-gender stratified sample of 205,795 people without a diagnosis of dementia from 2001 to 2010. The THIN database does not distinguish nursing home (care home) residents from those who live in their own homes.
Men with a diagnosis of dementia had an annual rate of first diagnosis of urinary incontinence of 42.3 (95% confidence interval, 40.9.8) per 1000, compared with 19.8 (19.4.3) per 1000 men without a dementia diagnosis. Among women, the rates of a first diagnosis of urinary incontinence were 33.5 (32.6.5) per 1000 women with a dementia diagnosis versus 18.6 (18.2.9) per 1000 women without a dementia diagnosis. Rates of a first diagnosis of fecal incontinence were 11.1 (10.4.9) per 1000 men with a dementia diagnosis versus 3.1 (2.9.3) per 1000 men without a dementia diagnosis. For women with a dementia diagnosis, 10.1 (9.6.6) per 1000 had a first diagnosis of fecal incontinence, versus 3.6 (3.5.8) per 1000 women without a dementia diagnosis. The adjusted rate ratio for first diagnosis of urinary incontinence was 3.2 (2.7.7) in men and 2.7 (2.3.2) in women, and for fecal incontinence was 6.0 (5.1.0) in men and 4.5 (3.8.2) in women.
The rate ratio of use of pharmacological treatment for urinary incontinence was 2.2 (1.4.7) for both genders, and for indwelling urinary catheters was 1.6 (1.3.9) in men and 2.3 (1.9.8) in women. Urinary catheters are known to increase the risk of urinary tract infection.
A limitation of the study was that the authors had to depend on coding of diagnoses and prescriptions in the database to determine the diagnosis of dementia and incontinence.
The authors state, "Incontinence is a common problem for community dwelling people with dementia. Providers and planners of services for dementia should anticipate high levels of need, including advice and support for carers managing incontinence. Some aspects of clinical management of urinary incontinence are different for patients with dementia compared with those without. Further study is required to understand the clinical reasoning of health care practitioners providing care for this population, particularly in the use of indwelling catheters, given the known risks."
###
Funding: The authors received no specific funding for this analysis of THIN but the resources were made possible through a programme grant from the National Institute for Health Research.
Competing Interests: SI seeks funding for research projects on the diagnosis and management of dementia syndrome. All other authors have declared that no competing interests exist.
Citation: Grant RL, Drennan VM, Rait G, Petersen I, Iliffe S (2013) First Diagnosis and Management of Incontinence in Older People with and without Dementia in Primary Care: A Cohort Study Using The Health Improvement Network Primary Care Database. PLoS Med 10(8): e1001505. doi:10.1371/journal.pmed.1001505
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:
http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001505
Contact:
Robert Grant
Senior Research Fellow
St George's, University of London
UNITED KINGDOM
+44 20 8725 2281
robert.grant@sgul.kingston.ac.uk
Dementia sufferers more likely to be diagnosed with urinary or fecal incontinence
2013-08-28
ELSE PRESS RELEASES FROM THIS DATE:
The importance of treating pediatric AIDS in the elimination agenda
2013-08-28
Scott Kellerman and colleagues argue that the scope of the current HIV elimination agenda must be broadened in order to ensure access to care and treatment for all children living with HIV.
In 2011, despite the global initiative to eliminate mother-to-child transmission of HIV, 330,000 new pediatric infections were added worldwide to the existing pool of 3.4 million children living with the virus. Children are more vulnerable to HIV infection and have higher morbidity and mortality. Without treatment, half of those children infected will die before the age of 2 years, ...
T-cell targeted therapy tested in type 1 diabetes study
2013-08-28
WA, Seattle (August 28, 2013) – Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network (ITN), are published today in The Lancet Diabetes & Endocrinology. The study did not meet its primary endpoint: at 12 months, insulin production, as measured by C-peptide responses, showed no difference in overall decline between the treatment and placebo groups.
Thymoglobulin®, currently licensed for the treatment of organ ...
Broccoli could be key in the fight against osteoarthritis
2013-08-28
A compound found in broccoli could be key to preventing or slowing the progress of the most common form of arthritis, according to new research led by the University of East Anglia (UEA).
Results from the laboratory study show that sulforaphane slows down the destruction of cartilage in joints associated with painful and often debilitating osteoarthritis. The researchers found that mice fed a diet rich in the compound had significantly less cartilage damage and osteoarthritis than those that were not.
The study, which also examined human cartilage cells and cow cartilage ...
Joslin scientists identify genetic variant associated with coronary heart disease in type 2 diabetes
2013-08-28
BOSTON -- August 27, 2013 -- Joslin scientists, in collaboration with researchers from the Harvard School of Public Health and Italian research institutes, have identified a previously unknown genetic variant associated with an increased risk of coronary heart disease (CHD) in type 2 diabetic patients. This discovery has the potential to lead to the development of new treatments for CHD in diabetic patients. The findings appear in the [month] issue of the Journal of the American Medical Association (JAMA).
CHD is the leading cause of morbidity and mortality among diabetic ...
Genetic variant identified that may increase heart disease risk among people with type 2 diabetes
2013-08-28
Boston, MA — A newly discovered genetic variant may increase the risk of heart disease in people with type 2 diabetes by more than a third, according to a study led by researchers at Harvard School of Public Health (HSPH) and Joslin Diabetes Center. It is the first genome-wide association study (GWAS) to identify a novel genetic variant associated with coronary heart disease (CHD) in people with type 2 diabetes, who have a two- to four-fold higher risk of heart disease compared with those without diabetes. The finding could lead to new interventions aimed at preventing ...
Zealous imaging fuelling unnecessary and harmful treatment of low risk thyroid cancers
2013-08-28
New technologies such as ultrasound, CT and MRI scanning can detect thyroid nodules as small as 2mm – many of these small nodules are papillary thyroid cancers.
In the US, cases have tripled in the past 30 years - from 3.6 per 100,000 in 1973 to 11.6 per 100,000 in 2009 – making it one of the fastest growing diagnoses. Yet the death rate from papillary thyroid cancer has remained stable.
This expanding gap between incidence of thyroid cancer and deaths suggests that low risk cancers are being overdiagnosed and overtreated, argue Dr Juan Brito and colleagues at the ...
The extraordinary evolution of REVs
2013-08-28
A new study by Anna Maria Niewiadomska and Robert Gifford, of The Aaron Diamond AIDS Research Center, New York, reveals that reticuloendotheliosis viruses (REVs), which originated in mammals, spread to birds as a result of medical intervention. Their findings will be published August 27 in the open access journal PLOS Biology.
"We became intrigued by these viruses", says Gifford, "…because their distribution in nature suggests something very unusual has occurred during their evolution."
The reticuloendotheliosis viruses (REVs) are retroviruses that were first identified ...
Size of personal space is affected by anxiety
2013-08-28
The space surrounding the body (known by scientists as 'peripersonal space'), which has previously been thought of as having a gradual boundary, has been given physical limits by new research into the relationship between anxiety and personal space.
New findings have allowed scientists to define the limit of the 'peripersonal space' surrounding the face as 20-40cm away. The study is published today in The Journal of Neuroscience.
As well as having numerical limits the specific distance was found to vary between individuals. Those with anxiety traits were found to have ...
Combination drug regimen may benefit patients with hepatitis C
2013-08-28
Treatment of chronic hepatitis C virus (HCV) genotype 1 infection with the interferon-free regimen of sofosbuvir and ribavirin resulted in a high sustained virologic response rate in a patient population with unfavorable treatment characteristics, according to a study in the August 28 issue of JAMA.
"Chronic infection with hepatitis C virus is a major cause of chronic liver disease, end-stage liver disease, hepatocellular cancer and remains the leading indication for liver transplants in western countries. The HCV epidemic in the United States is centered in large urban ...
Study examines relationship of a commercial ACO contract with medical spending
2013-08-28
Payment incentives implemented with a commercial accountable care organization (ACO) initiative in Massachusetts –Blue Cross Blue Shield's Alternative Quality Contract (AQC) – were associated with lower spending for Medicare enrollees served by the provider groups participating in the AQC, findings that suggest that evaluations of ACO programs may need to consider the implications for other patient populations to assess their full clinical and economic benefits, according to a study in the August 28 issue of JAMA.
"In response to mounting pressures to deliver more cost-effective ...